압박요법 시장 규모, 점유율, 성장, 세계 산업 분석, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of compression therapy Market

The global compression therapy market size was valued at USD 4.58 billion in 2025 and is projected to reach USD 4.89 billion in 2026 and USD 8.15 billion by 2034. The market is supported by the increasing prevalence of venous and lymphatic disorders, a growing geriatric population, rising awareness of compression-based treatment, and continuous product innovation. North America dominated the compression therapy market with a 34.77% share in 2025, supported by advanced healthcare infrastructure, high healthcare expenditure, strong research activities, and increasing prevalence of lymphedema and venous leg ulcers.

Market Definition and Scope

Compression therapy is a clinically established treatment approach that applies controlled pressure to the limbs to improve venous blood circulation and support lymphatic drainage. It is widely used for managing lymphedema, venous leg ulcers, deep vein thrombosis, chronic venous insufficiency, and other vascular conditions. Products include compression garments, compression pumps, and other specialized systems. Growing adoption across hospitals, clinics, nursing care centers, and home-care settings is expanding the market. Technological improvements are also creating more comfortable, effective, and patient-friendly compression solutions.

Market Dynamics

Drivers - Increasing Prevalence of Venous and Lymphatic Disorders

The rising incidence of lymphedema, venous leg ulcers, varicose veins, and deep vein thrombosis is a major factor supporting market growth. Immobility, obesity, pregnancy, previous thrombosis, surgeries, and chronic venous insufficiency can increase the risk of these conditions. Growing awareness of compression garments and pneumatic compression devices is encouraging healthcare professionals and patients to adopt these treatment options.

Trends - Growing Adoption of Advanced Compression Garments

Compression garments are increasingly being used as an effective option for managing chronic venous and lymphatic disorders. Manufacturers are introducing advanced garments and multi-component compression systems designed to improve pressure distribution, comfort, and treatment effectiveness. Increasing product development and clinical research are further supporting adoption.

Restraints - High Cost and Limited Awareness

The high cost of compression pumps and limited awareness of compression therapy in developing countries remain important challenges. Patients and healthcare providers in emerging markets may have restricted access to advanced products because of affordability, inadequate healthcare infrastructure, and limited knowledge about available treatment options.

Impact of COVID-19

The COVID-19 pandemic disrupted healthcare services, elective treatments, product manufacturing, and distribution networks. Reduced hospital visits and delays in non-emergency procedures affected demand for certain compression therapy products. However, the increased focus on home-based healthcare and remote patient management created opportunities for products suitable for independent use. Healthcare providers also placed greater emphasis on treatment approaches that could reduce unnecessary hospital visits, supporting long-term interest in home-care compression solutions.

Segmentation Analysis

By Product

The market is segmented into compression garments, compression pumps, and others. Compression garments dominated the market and accounted for 71.8% of the market in 2025, supported by their broad use in venous and lymphatic disease management. Compression pumps are expected to experience strong growth due to increasing adoption for lymphedema treatment and continued product launches.

By Application

Applications include venous leg ulcer, DVT, lymphedema, and others. Lymphedema represents a major application area because of the increasing patient population and growing use of compression pumps and garments. Venous leg ulcers also contribute significantly due to their prevalence among elderly patients and individuals with chronic venous conditions.

By End User

The market includes hospitals & clinics, nursing care centers, home care, and others. Hospitals & clinics are expected to maintain a leading position because of skilled healthcare professionals, advanced treatment facilities, product availability, and favorable reimbursement conditions. Home care is gaining momentum as the geriatric population increases and patients seek convenient treatment options.

Regional Insights

North America

North America led the market, with a regional market value of USD 1.05 billion in the reported regional analysis. High R&D investment, product launches, developed healthcare infrastructure, and the prevalence of lymphedema and venous diseases support regional demand.

Europe

Europe is expected to maintain its position as a significant market, supported by new product launches, established healthcare systems, and increasing awareness of compression-based treatment. Growing demand for advanced solutions is encouraging manufacturers to strengthen their presence across European countries.

Asia Pacific

Asia Pacific is projected to register the fastest growth, supported by an expanding geriatric population, increasing disposable income, improving healthcare infrastructure, and a growing patient pool suffering from chronic venous and lymphatic disorders. Japan is expected to reach USD 246.0 million by 2025.

Latin America and Middle East & Africa

Latin America and the Middle East & Africa are expected to experience moderate expansion as healthcare infrastructure improves and advanced compression products become more accessible. Increasing unmet medical needs and growing awareness are supporting opportunities across these regions.

Competitive Landscape

Key companies operating in the compression therapy market include SIGVARIS, 3M, Arjo, PAUL HARTMANN Pty. Ltd., medi GmbH & Co. KG, Essity Aktiebolag, Smith & Nephew, Bio Compression Systems, Inc., and Tactile Systems Technology, Inc. Companies are focusing on new product development, distribution expansion, strategic partnerships, acquisitions, and portfolio diversification to strengthen their market positions.

Key Industry Developments

Koya Medical received FDA clearance for its compression therapy system designed for the lower extremities. DeRoyal entered a USD 1.2 million agreement with Tyndall and RCSI SWaT researchers to advance compression wound therapy. AIROS Medical introduced updated compression therapy products, including the AIROS 6 Sequential Compression Therapy device and Arm Plus garments. Theragun acquired RP Sports and its RecoveryPump clinical pneumatic compression technology product line.

Report Coverage

The compression therapy market report provides qualitative and quantitative insights into market size, market value, segmentation, regional analysis, competitive dynamics, product developments, and emerging opportunities. It evaluates compression garments, compression pumps, applications, and end-user categories while examining regional market conditions and major industry developments. The report also covers product innovation, strategic partnerships, mergers and acquisitions, regulatory developments, healthcare infrastructure, and changing treatment preferences.

Conclusion

The compression therapy market is positioned for continued growth as the prevalence of venous and lymphatic disorders increases and healthcare providers adopt advanced compression-based treatment solutions. The global market is projected to increase from USD 4.58 billion in 2025 to USD 4.89 billion in 2026 and USD 8.15 billion by 2034. Compression garments will remain a key product category, while compression pumps and home-care solutions are expected to create additional opportunities. Rising geriatric populations, improved healthcare infrastructure, product innovation, and greater awareness of effective vascular and lymphatic disease management will remain important factors shaping the market.

Unit Value (USD billion)

Segmentation By Product

• Compression Garments
• Compression Bandages
• Compression Stockings
• Others
• Compression Pumps
• Others

By Application

• Venous Leg Ulcer
• Deep Vein Thrombosis (DVT)
• Lymphedema
• Others

By End User

• Hospitals & Clinics
• Nursing Care Centers
• Home Care Settings
• Others

By Geography

• North America (the U.S. and Canada)
• Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)
• Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia- Pacific)
• Latin America (Brazil, Mexico, and the Rest of Latin America)
• Middle East & Africa (South Africa, GCC and the Rest of Middle East &Africa)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities

4. Key Insights

• 4.1. Prevalence of Venous Leg Ulcer, DVT, Lymphedema and other key indications by country/region
• 4.2. Key Industry Trends
• 4.3. Key Industry Developments (Mergers, Acquisitions, and Partnerships)
• 4.4. New Product Launches

5. Global Compression Therapy Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Key Findings / Summary
• 5.2. Market Analysis, Insights and Forecast - By Product
  • 5.2.1. Compression Garments
    • 5.2.1.1. Compression Bandages
    • 5.2.1.2. Compression Stockings
    • 5.2.1.3. Others
  • 5.2.2. Compression Pumps
  • 5.2.3. Others
• 5.3. Market Analysis, Insights and Forecast - By Application
  • 5.3.1. Venous Leg Ulcer
  • 5.3.2. Deep Vein Thrombosis
  • 5.3.3. Lymphedema
  • 5.3.4. Others
• 5.4. Market Analysis, Insights and Forecast - By End User
  • 5.4.1. Hospitals & Clinics
  • 5.4.2. Nursing Care Centers
  • 5.4.3. Home Care
  • 5.4.4. Others
• 5.5. Market Analysis, Insights and Forecast - By Country
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa

6. North America Compression Therapy Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Key Findings / Summary
• 6.2. Market Analysis - By Product
  • 6.2.1. Compression Garments
    • 6.2.1.1. Compression Bandages
    • 6.2.1.2. Compression Stockings
    • 6.2.1.3. Others
  • 6.2.2. Compression Pumps
  • 6.2.3. Others
• 6.3. Market Analysis - By Application
  • 6.3.1. Venous Leg Ulcer
  • 6.3.2. Deep Vein Thrombosis
  • 6.3.3. Lymphedema
  • 6.3.4. Others
• 6.4. Market Analysis - By End User
  • 6.4.1. Hospitals & Clinics
  • 6.4.2. Nursing Care Centers
  • 6.4.3. Home Care
  • 6.4.4. Others
• 6.5. Market Analysis - By Country
  • 6.5.1. U.S.
  • 6.5.2. Canada

7. Europe Compression Therapy Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Key Findings / Summary
• 7.2. Market Analysis - By Product
  • 7.2.1. Compression Garments
    • 7.2.1.1. Compression Bandages
    • 7.2.1.2. Compression Stockings
    • 7.2.1.3. Others
  • 7.2.2. Compression Pumps
  • 7.2.3. Others
• 7.3. Market Analysis - By Application
  • 7.3.1. Venous Leg Ulcer
  • 7.3.2. Deep Vein Thrombosis
  • 7.3.3. Lymphedema
  • 7.3.4. Others
• 7.4. Market Analysis - By End User
  • 7.4.1. Hospitals & Clinics
  • 7.4.2. Nursing Care Centers
  • 7.4.3. Home Care
  • 7.4.4. Others
• 7.5. Market Analysis - By Country/Sub-region
  • 7.5.1. U.K.
  • 7.5.2. Germany
  • 7.5.3. France
  • 7.5.4. Spain
  • 7.5.5. Italy
  • 7.5.6. Scandinavia
  • 7.5.7. Rest of Europe

8. Asia Pacific Compression Therapy Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Key Findings / Summary
• 8.2. Market Analysis - By Product
  • 8.2.1. Compression Garments
    • 8.2.1.1. Compression Bandages
    • 8.2.1.2. Compression Stockings
    • 8.2.1.3. Others
  • 8.2.2. Compression Pumps
  • 8.2.3. Others
• 8.3. Market Analysis - By Application
  • 8.3.1. Venous Leg Ulcer
  • 8.3.2. Deep Vein Thrombosis
  • 8.3.3. Lymphedema
  • 8.3.4. Others
• 8.4. Market Analysis - By End User
  • 8.4.1. Hospitals & Clinics
  • 8.4.2. Nursing Care Centers
  • 8.4.3. Home Care
  • 8.4.4. Others
• 8.5. Market Analysis - By Country/Sub-region
  • 8.5.1. Japan
  • 8.5.2. China
  • 8.5.3. India
  • 8.5.4. Australia
  • 8.5.5. Southeast Asia
  • 8.5.6. Rest of Asia Pacific

9. Latin America Compression Therapy Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Key Findings / Summary
• 9.2. Market Analysis - By Product
  • 9.2.1. Compression Garments
    • 9.2.1.1. Compression Bandages
    • 9.2.1.2. Compression Stockings
    • 9.2.1.3. Others
  • 9.2.2. Compression Pumps
  • 9.2.3. Others
• 9.3. Market Analysis - By Application
  • 9.3.1. Venous Leg Ulcer
  • 9.3.2. Deep Vein Thrombosis
  • 9.3.3. Lymphedema
  • 9.3.4. Others
• 9.4. Market Analysis - By End User
  • 9.4.1. Hospitals & Clinics
  • 9.4.2. Nursing Care Centers
  • 9.4.3. Home Care
  • 9.4.4. Others
• 9.5. Market Analysis - By Country
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America

10. Middle East & Africa Compression Therapy Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Key Findings / Summary
• 10.2. Market Analysis - By Product
  • 10.2.1. Compression Garments
    • 10.2.1.1. Compression Bandages
    • 10.2.1.2. Compression Stockings
    • 10.2.1.3. Others
  • 10.2.2. Compression Pumps
• 10.3. Others
• 10.4. Market Analysis - By Application
  • 10.4.1. Venous Leg Ulcer
  • 10.4.2. Deep Vein Thrombosis
  • 10.4.3. Lymphedema
  • 10.4.4. Others
• 10.5. Market Analysis - By End User
  • 10.5.1. Hospitals & Clinics
  • 10.5.2. Nursing Care Centers
  • 10.5.3. Home Care
  • 10.5.4. Others
• 10.6. Market Analysis - By Country/Sub-region
  • 10.6.1. GCC Countries
  • 10.6.2. South Africa
  • 10.6.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Key Industry Developments
• 11.2. Global Market Share Analysis (2025)
• 11.3. Competition Dashboard
• 11.4. Comparative Analysis - Major Players
• 11.5. Company Profiles
  • 11.5.1. SIGVARIS
    • 11.5.1.1. Overview,
    • 11.5.1.2. Products & services,
    • 11.5.1.3. SWOT analysis,
    • 11.5.1.4. Recent developments,
    • 11.5.1.5. strategies,
    • 11.5.1.6. financials (based on availability)
  • 11.5.2. 3M
    • 11.5.2.1. Overview,
    • 11.5.2.2. Products & services,
    • 11.5.2.3. SWOT analysis,
    • 11.5.2.4. Recent developments,
    • 11.5.2.5. strategies,
    • 11.5.2.6. financials (based on availability)
  • 11.5.3. Arjo
    • 11.5.3.1. Overview,
    • 11.5.3.2. Products & services,
    • 11.5.3.3. SWOT analysis,
    • 11.5.3.4. Recent developments,
    • 11.5.3.5. strategies,
    • 11.5.3.6. financials (based on availability)
  • 11.5.4. PAUL HARTMANN Pty. Ltd
    • 11.5.4.1. Overview,
    • 11.5.4.2. Products & services,
    • 11.5.4.3. SWOT analysis,
    • 11.5.4.4. Recent developments,
    • 11.5.4.5. strategies,
    • 11.5.4.6. financials (based on availability)
  • 11.5.5. medi GmbH & Co. KG
    • 11.5.5.1. Overview,
    • 11.5.5.2. Products & services,
    • 11.5.5.3. SWOT analysis,
    • 11.5.5.4. Recent developments,
    • 11.5.5.5. strategies,
    • 11.5.5.6. financials (based on availability)
  • 11.5.6. Essity Aktiebolag (publ)
    • 11.5.6.1. Overview,
    • 11.5.6.2. Products & services,
    • 11.5.6.3. SWOT analysis,
    • 11.5.6.4. Recent developments,
    • 11.5.6.5. strategies,
    • 11.5.6.6. financials (based on availability)
  • 11.5.7. Smith & Nephew
    • 11.5.7.1. Overview,
    • 11.5.7.2. Products & services,
    • 11.5.7.3. SWOT analysis,
    • 11.5.7.4. Recent developments,
    • 11.5.7.5. strategies,
    • 11.5.7.6. financials (based on availability)
  • 11.5.8. Bio Compression Systems, Inc.
    • 11.5.8.1. Overview,
    • 11.5.8.2. Products & services,
    • 11.5.8.3. SWOT analysis,
    • 11.5.8.4. Recent developments,
    • 11.5.8.5. strategies,
    • 11.5.8.6. financials (based on availability)
  • 11.5.9. Tactile Systems Technology, Inc.
    • 11.5.9.1. Overview,
    • 11.5.9.2. Products & services,
    • 11.5.9.3. SWOT analysis,
    • 11.5.9.4. Recent developments,
    • 11.5.9.5. strategies,
    • 11.5.9.6. financials (based on availability)
  • 11.5.10. Other Players
    • 11.5.10.1. Overview,
    • 11.5.10.2. Products & services,
    • 11.5.10.3. SWOT analysis,
    • 11.5.10.4. Recent developments,
    • 11.5.10.5. strategies,
    • 11.5.10.6. financials (based on availability)